Appello Pharmaceuticals Competitors and Similar CompaniesClear all

Appello Pharmaceuticals's competitors and similar companies include Bioasis Technologies, Genfit and Roche.

	Appello Pharmaceuticals Appello Pharmaceuticals is a preclinical-stage company that discovers and develops novel positive allosteric modulators for the treatment of Parkinson's disease.	Bioasis Technologies Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.	Roche Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
Founding Date	Founding Date N/A	Founding Date 2007	Founding Date 1999	Founding Date 1896
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations Nashville, US HQ	Locations New Haven, US HQ Burnaby, CA	Locations Loos, FR HQ Cambridge, US	Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR North Ryde, AU Sydney, AU Wien, AT Dhaka, BD see more
Employees	Employees N/A	Employees N/A	Employees 180	Employees 103,249
Valuation ($)	Valuation ($) N/A	Valuation ($) 288.9 k	Valuation ($) 280.8 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €65.4m (FY, 2025)	Revenue (est.) CHF61.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €302k (FY, 2025)	Cost of goods CHF13.1b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €70.8m (FY, 2025)	Gross profit CHF50.5b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income (€86m) (FY, 2025)	Net income CHF13.8b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 10.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 7.8b

For sources of this data, please see the company profile

View Company Profiles

Bioasis Technologies

New Haven, US

Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases.

View company

Genfit

Loos, FR

Employees

180

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.

View company

Roche

Basel, CH

Employees

103,249

Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.